Alexos and Sheehan have been on the board since June 2006 and both were appointed by the Sirona Holdings Luxco SCA, the investment firm that bought Sirona in 2005.
After the latest departures, the board will consist in six independent directors and three members of the Sirona management team.
Samsung Biologics honoured at 2026 CDMO Leadership Awards
Frost & Sullivan names Abzena a market-leading ADC CDMO
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
SportsMed Physical Therapy named Physical Therapy Company of the Year
Ensorcell adds new senior leadership team members
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme